#  Known Bioactives 

 



SortLibrary NameNumber of CompoundsNumber of PlatesICCB-L Plate Numbers[**Biomol 4 - FDA Approved Library**](/biomol-4-fda-approved-library)

640

2

2089-2090

[**Biomol ICCBL - 2017**](/biomol-iccb-l-known-bioactives-2017)

470

2

3854-3855

[**Cayman Biolipid 1**](/cayman-biolipid-1)

831

3

3648-3650

[**EMD Kinase Inhibitor 1**](/emd-kinase-inhibitor-1)

244

1

3229

[**eMolecules 2014**](/emolecules)

248

1

3604

[**LOPAC 1**](/lopac1)

1,280

4

3260-3263

[**Ludwig Anti-Cancer**](/ludwig-selleck-anti-cancer-library?admin_panel=1&login=1)

386 (x9)

16

3679-3694

[**Mechanism of Action - 10mM**](/iccb-longwood-mechanism-action-library-10mm)

1245

16

3740-3755

[**Mechanism of Action**](/iccb-longwood-mechanism-action-library)

1245 (x4)

16

3720-3735

[**MedChemExpress Mitochondrial Library**](/medchemexpress-mitochondrial-library?admin_panel=1)

416

2

6018-6019

[**MicroSource 1 - US Drug Collection**](/microsource-1-us-drug-collection)

1,040

4

2091-2094

[**MSDiscovery 1**](/msdiscovery-1)

270

1

3264

[**NINDS Custom Collection 2**](/ninds-custom-collection-2)

1,040

4

1920-1923

[**Prestwick 3 (at 2 concentrations)**](/prestwick-3-collection)

1,280

4

3712-3715, 3716-3719

[**Selleck (at 3 concentrations)**](/selleck-bioactive-compound-library)

1,902

7

3651-3657, 3658-3664, 3665-3671

[**Selleck FDA-Approved 2023**](/selleck-fda-approved-2023)

2,816

9

5079-5087

[**Selleck Neuronal (at 2 concentrations)**](/selleck-neuronal-signaling-compound-library)

1,031

4

3884-3887, 3888-3891

[**SYNthesis Kinase Inhibitor 2**](/synthesis-kinase-inhibitor-2)

96 (x3)

1

3580

[**Tocris Mini 3**](/tocriscreen%E2%84%A2-mini-library-3)

1,120

4

3675-3678





If you have screened a library at ICCB-L that you cannot find on this list, please check the [retired](/retired-libraries) libraries list.



 

Matrix illustrating the overlap between libraries in the Known Bioactive and Academic Collections at ICCB-L *(updated August 2023)*.

 ![Compound Library Overlap Matrix](/sites/g/files/omnuum5406/files/iccb/files/library_overlap_matrix_aug2023.jpg)

 

[Image](https://iccb.med.harvard.edu/sites/g/files/omnuum5406/files/iccb/files/library_overlap_matrix_aug2023.jpg)



 

Graph displaying the clinical phases of ICCB-L Known Bioactive and Academic Libraries, based on the [Drug Repurposing Hub](https://repo-hub.broadinstitute.org/repurposing#home) and displayed in Screensaver, Study #100012 (*updated August 2023*).

 ![CLUE Summary](/sites/g/files/omnuum5406/files/iccb/files/clue_summary_aug2023.png)

 

[Image ](https://iccb.med.harvard.edu/sites/g/files/omnuum5406/files/iccb/files/clue_summary_aug2023.png)



 

Graph highlighting unique to total compounds in ICCB-L Known Bioactive and Academic Libraries *(updated August 2023).*

 ![Unique to Total Compound Comparison](/sites/g/files/omnuum5406/files/iccb/files/unique_to_total_compounds_aug2023.png)

 

[Image](https://iccb.med.harvard.edu/sites/g/files/omnuum5406/files/iccb/files/unique_to_total_compounds_aug2023.png)



 

Graph illustrating the percent of unique compounds in the indicated library that are not represented in other ICCB-L libraries *(updated August 2023).*

 ![Library Percent Overlap](/sites/g/files/omnuum5406/files/iccb/files/library_percent_overlap_aug2023.png)

 

[Image](https://iccb.med.harvard.edu/sites/g/files/omnuum5406/files/iccb/files/library_percent_overlap_aug2023.png)